W Venus So
Overview
Explore the profile of W Venus So including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Esteban R, Duarte J, Teixeira P, Richard F, Koltsova S, So W
Cytometry B Clin Cytom
. 2022 Mar;
102(3):220-227.
PMID: 35253974
Background: A key step in clinical flow cytometry data analysis is gating, which involves the identification of cell populations. The process of gating produces a set of reportable results, which...
2.
So W, Yang T, Yang X, Zhi J
Cancer Chemother Pharmacol
. 2018 Dec;
83(1):209-213.
PMID: 30511219
Purpose: Idasanutlin is a selective small-molecule MDM2 antagonist. It activates the tumor suppressor TP53 and is in phase 3 clinical trial for acute myeloid leukemia. Nonclinical studies have shown that...
3.
Peng Z, Gillespie P, Weisel M, So S, So W, Kondru R, et al.
Mol Inform
. 2016 Aug;
32(4):337-45.
PMID: 27481590
No abstract available.
4.
Deng W, Schneider G, So W
Mol Inform
. 2016 Jul;
30(8):665-71.
PMID: 27467258
No abstract available.
5.
Tanrikulu Y, Kondru R, Schneider G, So W, Bitter H
Mol Inform
. 2016 Jul;
29(10):678-84.
PMID: 27464011
Relationships between drug targets and associated diseases have traditionally been investigated by means of sequence similarity, comparative protein modeling, and pathway analysis. Recently, a complementary paradigm has emerged to link...
6.
Reis B, Jukofsky L, Chen G, Martinelli G, Zhong H, So W, et al.
Haematologica
. 2016 Feb;
101(5):e185-8.
PMID: 26869629
No abstract available.
7.
Weisel M, Bitter H, Diederich F, So W, Kondru R
J Chem Inf Model
. 2012 May;
52(6):1450-61.
PMID: 22582806
A central problem in structure-based drug design is understanding protein-ligand interactions quantitatively and qualitatively. Several recent studies have highlighted from a qualitative perspective the nature of these interactions and their...
8.
Wei X, Hoffman A, Hamilton S, Xiang Q, He Y, So W, et al.
Bioinformatics
. 2011 Dec;
28(3):301-5.
PMID: 22155864
Motivation: Cell-based phenotypic screens using small molecule inhibitors is an important technology for early drug discovery if the relationship between the disease-related cellular phenotype and inhibitors' biological targets can be...
9.
Deng W, Berthel S, So W
J Chem Inf Model
. 2011 Mar;
51(3):511-20.
PMID: 21381694
A Markush, or generic structure, is a widely used convention in chemical and pharmaceutical patents. The flexibility and complexity of this format, however, preclude an easy understanding and analysis of...
10.
Yang X, Ongusaha P, Miles P, Havstad J, Zhang F, So W, et al.
Nature
. 2008 Feb;
451(7181):964-9.
PMID: 18288188
Glucose flux through the hexosamine biosynthetic pathway leads to the post-translational modification of cytoplasmic and nuclear proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc). This tandem system serves as a nutrient sensor to...